Meeting
2016 ASCO Annual Meeting
Clinical Impact of extensive molecular profiling (EMP) in advanced cancer patients (pts) referred to early phase trial unit: The BIP (Bergonie Institute Profiling) Program.
Authors
Sophie Cousin
Institut Bergonié, Bordeaux, France
Sophie Cousin , Maud Toulmonde , Thomas Grellety , Celine Auzanneau , Emmanuel Khalifa , Yec'han Laizet , Kevin Tran , Anne Floquet , Delphine Garbay , Jacques Robert , Isabelle Hostein , Isabelle Soubeyran , Antoine Italiano
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Tumor Biology
Track
Tumor Biology
Sub Track
Tumor-Based Biomarkers
Clinical Trial Registration Number
NCT02534649
Citation
J Clin Oncol 34, 2016 (suppl; abstr 11593)
DOI
10.1200/JCO.2016.34.15_suppl.11593
Abstract #
11593
Poster Bd #
290
Abstract Disclosures
Similar Posters
Poster
2019 Gastrointestinal Cancers Symposium
Genomic alterations in appendiceal carcinoma using circulating DNA.
First Author: Walid Labib Shaib
Poster
2018 ASCO Annual Meeting
Seventeen percent of NGS 50 gene panel variants are not expressed in RNAseq.
First Author: Razelle Kurzrock
Poster
2017 Gastrointestinal Cancers Symposium
Parallel sequencing of a 50 genes panel in metastatic colorectal cancer (MCRC) patients (pts) treated with intensive first-line FIr-B/FOx triplet chemotherapy plus bevacizumab (BEV): Preliminary data and clinical outcome.
First Author: Gemma Bruera
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Genomic classification of clinically advanced pancreatic ductal adenocarcinoma (PDAC) based on methylthioadenosine phosphorylase (MTAP) genomic loss (MTAP loss).
First Author: Natalie Ngoi